Effect of metacycloprodigiosin, an inhibitor of killer T cells, on murine skin and heart transplants

Journal of Antibiotics

Volumn 49, Issue 1, 1996, Pages 86-90

  Magae, Junji ^a,b,c   Miller, Matthew W ^a   Nagai, Kazuo ^b   Shearer, Gene M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

^c NATL INST BIOSCI HUM TECHNOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CYCLOSPORIN A; METACYCLOPRODIGIOSIN; UNCLASSIFIED DRUG;

ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; CELL ACTIVITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SKIN GRAFT;

EID: 0030050684     PISSN: 00218820     EISSN: None     Source Type: Journal    
DOI: 10.7164/antibiotics.49.86     Document Type: Article

References (32)

1. ROSENBERG, A. S. & A. SINGER: Cellular basis of skin allograft rejection: an in vivo model of immune-mediated tissue destruction. Annu. Rev. Immunol. 10: 333-358, 1992
2. LAFFERTY, K. J.; S. J. PROWSE, C. J. SIMEONOVIC & H. S. WARREN: Immunobiology of tissue transplantation: a return to the passenger leukocyte concept. Annu. Rev. Immunol. 1: 143-173, 1983
3. MINTZ, B. & W. K. SILVERS: "Intrinsic" immunological tolerance in allophenic mice. Science 158: 1484-1487, 1967
4. MINTZ, B. & W. K. SILVERS: Histocompatibility antigens on melanoblasts and hair follicle cells. Cell-localized homograft rejection in allophenic skin grafts. Transplantation 9: 497-505, 1970
5. HALL, B. M. & S. E. DORSCH: Cells mediating allograft rejection. Immunol. Rev. 77: 31-59, 1984
6. MASON, D. W.; M. J. DALLMAN, R. P. ARTHUR & P. J. MORRIS: Mechanisms of allograft rejection: the roles of cytotoxic T-cells and delayed type hypersensitivity. Immunol. Rev. 77: 167-184, 1984
7. STEINMULLER, D.: Which T cells mediate allograft rejection? Transplantation 40: 229-233, 1985
8. MASON, D. W. & P. J. MORRIS: Effector mechanisms in allograft rejection. Annu. Rev. Immunol. 4: 119-145, 1986
9. HALL, B. M.: Cells mediating allograft rejection. Transplantation 51: 1141-1151, 1991
10. HARASHIMA, K.; N. TSUCHIDA, T. TANAKA & J. NAGATSU: Prodigiosin 25-C: Isolation and the chemical structure. Agric. Biol. Chem. 31: 481-489, 1967
11. WASSERMAN, H. H.; G. C. RODGERS & D. D. KEITH: Undecylprodigiosin. Tetrahedron 32: 1851-1854, 1976
12. NAKAMURA, A.; K. NAGAI, S. SUZUKI, K. ANDO & G. TAMURA: Selective suppression by prodigiosm of the mitogenic response of murine splenocytes. J. Antibiotics 39: 1155-1159, 1986
13. NAKAMURA, A.; J. MAGAE, R. F. TSUJI, M. YAMASAKI & K. NAGAI: Suppression of cytotoxic T cell induction in vivo by prodigiosin 25-C. Transplantation 47: 1013-1016, 1989
14. TSUJI, R. F.; M. YAMAMOTO, A. NAKAMURA, T. KATAOKA, J. MAGAE, K. NAGAI & M. YAMASAKI: Selective immunosuppression of prodigiosin 25-C and FK506 in the murine immune system. J. Antibiotics 43: 1293-1301, 1990
15. TSUJI, R. F.; J. MAGAE, M. YAMASHITA, K. NAGAI & M. YAMASAKI: Immunomodulating properties of prodigiosin 25-C, an antibiotic which preferentially suppresses induction of cytotoxic T cells. J. Antibiotics 45: 1295-1302, 1992
16. KATAOKA, T.; J. MAGAE, H. NARIUCHI, M. YAMASAKI & K. NAGAI: Enhancement by concanavalin A of the suppressive effect of prodigiosin 25-C on proliferation of murine splenocytes. J. Antibiotics 45: 1303-1312, 1992
17. +-ATPase inhibitors. J. Antibiotics 45: 1618-1625, 1992
18. +-ATPase, inhibits vacuolar acidification and affects glycoprotein processing. FEBS lett. 359: 53-59, 1995
19. MELLMAN, I.; R. FUCKS & A. HELENIUS: Acidification of the endocytic and exocytic pathways. Annu. Rev. Biochem. 55: 663-700, 1986
20. KATAOKA, T.; K. TAKAKU, J. MAGAE, N. SHINOHARA, H. TAKAYAMA, S. KONDO & K. NAGAI: Acidification is essential for maintaining the structure and function of lytic granules of cytotoxic T lymphocytes. J. Immunol. 153: 3938-3947, 1994
21. FULMER, R. I.; A. T. CRAMER, R. A. LIEBELT & A. G. LIEBELT: Transplantation of cardiac tissue into the mouse ear. Am. J. Anat. 113: 273-281, 1963
22. ROSENBERG, A. S.; T. MIZUOCHI, S. O. SHARROW & A. SINGER: Phenotype, specificity and function of T cell subsets and T cell interactions involved in skin allograft rejection. J. Exp. Med. 165: 1296-1315, 1987
23. + cells in skin graft rejection in the mouse. Transplantation 44: 273-280, 1987
24. + T cell subsets. Transplantation 41: 634-639, 1986
25. MADSEN, J. C.; W. M. PEUGH, K. J. WOOD & P. J. MORRIS: The effect of anti-L3T4 monoclonal antibody treatment on first-set rejection of murine cardiac allografts. Transplantation 44: 849-852, 1989
26. COBBOLD, S. P.; A. JAYASURIYA, A. NASH, T. D. PROSPERO & H. WALDMANN: Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo. Nature 312: 548-551, 1985
27. GRUSBY, M. J.; H. AUCHINCLOSS Jr., R. LEE, R. S. JOHNSON, J. P. SPENCER, M. ZIJLSTRA, R. JAENISCH, V. E. PAPAIOANNOU & L. H. GLIMCHER: Mice lacking major histocompatibility complex class I and class II molecules. Proc. Natl. Acad. Sci. U.S.A. 90: 3913-3917, 1993
28. IMAGAWA, D. K.; J. M. MILLIS, K. M. OLTHOFF, P. SEU, R. A. DEMPSEY, J. HART, P. I. TERASAKI, E. M. WASEF & R. W. BUSULTIL: The role of tumor necrosis factor in allograft rejection: II. Evidence that antibody therapy against tumor necrosis factor-alpha and lymphotoxin enhances cardiac allograft survival in rats. Transplantation 50: 189-193, 1990
29. SCHRINGE, M.; R. W. F. DE BRUIN, H. JEEKEL & R. L. MARQUET: Anti-tumor necrosis factor alpha serum prolongs heart allograft survival in rat. Transplant. Proc. 23: 547-548, 1991
30. TSCHOPP, J. & M. NABHOLZ: Perforin-mediated target cell lysis by cytolytic T lymphocytes. Annu. Rev. Immunol. 8: 279-302, 1990
31. LOWIN, B.; M. HAHNE, C, MATTMANN & J. TSCHOPP: Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways. Nature 370: 651-652, 1994
32. KÄGI, D.; F. VIGNAUX, B. LEDERMANN, K. BÜRKI, V. DEPRAETERE, S. NAGATA, H. HENGARTNER & P. GOLSTEIN: Fas and perforin pathways as major mechanism of T cell-mediated cytotoxicity. Science 265: 528-530, 1994